Background illustration for clinical trials search

Paid Clinical Trials Escondido

Discover 1,807 paid clinical trials in Escondido, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

for
Colorectal Neoplasms
Location: La Jolla CA, Duarte CA, Weston FL, Philadelphia PA,
Sponsor: Surgimab

Sex: All

Age: 18+

Code: NCT03659448

Phase 3, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: La Jolla CA, Duarte CA, Santa Monica CA, Phoenix AZ,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: La Jolla CA, Newport Beach CA, Duarte CA,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase 2, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: La Jolla CA, Loma Linda CA, Torrance CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase 2, Recruiting

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: La Jolla CA, San Diego CA, Palo Alto CA, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04628767

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for
Lung Non-Small Cell Carcinoma
Location: La Jolla CA, Loma Linda CA, Modesto CA, Sunnyvale CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06116682

Phase 2, Recruiting

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

for
Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
Location: La Jolla CA, Abilene TX, Denton TX, Dallas TX,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05727176

Phase 2, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: La Jolla CA, San Diego CA, Orange CA, Loma Linda CA,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase 3, Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for
Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
Location: La Jolla CA, Burbank CA, Pahrump NV, Kingman AZ,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase 2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: La Jolla CA, San Diego CA, Irvine CA, Newport Beach CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System

for
Cholecystectomy, Robotic
Location: San Diego CA, Los Angeles CA
Sponsor: CMR Surgical Ltd

Sex: All

Age: 22+

Code: NCT07096856

Recruiting

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

for
Symptomatic Genetic Dilated Cardiomyopathy
Location: San Diego CA, Los Angeles CA, Stanford CA,
Sponsor: Kardigan, Inc.

Sex: All

Age: 18+

Code: NCT07210723

Phase 2, Phase 3, Recruiting

SuperSaturated Oxygen Comprehensive Observational Registry

for
STEMI - ST Elevation Myocardial Infarction, AMI
Location: La Jolla CA, San Diego CA, Laguna Hills CA,
Sponsor: TherOx

Sex: All

Age: 18 - 70+

Code: NCT06438315

Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: La Jolla CA, San Diego CA, Orange CA, Loma Linda CA,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase 3, Recruiting

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

for
Chronic Heart Failure, CKD Stage 3
Location: La Jolla CA, San Francisco CA, Austin TX,
Sponsor: AquaPass Medical Ltd.

Sex: All

Age: 21 - 70+

Code: NCT06360380

Recruiting

Incidence of Long-TeRm Atrial Fibrillation After Acute Illness

for
Atrial Fibrillation (AF)
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT07434674

Recruiting

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

for
Atrial Fibrillation (AF), Persistant Atrial Fibrillation,
Location: San Diego CA, Phoenix AZ, San Antonio TX, Austin TX,
Sponsor: Arga Medtech SA

Sex: All

Age: 18 - 70+

Code: NCT06784466

Recruiting

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: La Jolla CA, Pasadena CA, Stanford CA, San Francisco CA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase 3, Recruiting

The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)

for
Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease,
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 40 - 70+

Code: NCT05237505

Phase 2, Recruiting

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

for
Hypertrophic Cardiomyopathy
Location: La Jolla CA, San Francisco CA, Houston TX, Rochester MN,
Sponsor: Tenaya Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05836259

Phase 1, Phase 2, Recruiting